IP Library Granted Patent US 9,694,117
Granted Patent B2
US 9,694,117 · App. 14/627,351 · Granted Jul 4, 2017

Antithrombotic medical materials and medical apparatus using the same materials

Inventor: Takao Anzai (Kanagawa, JP)
Assignee: TERUMO KABUSHIKI KAISHA
A61L33/064
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,694,117
App. No.
14/627,351
Granted
Jul 4, 2017
Kind
B2
Abstract

A medical material that is excellent in antithrombogenicity even under a severe use condition in which thrombi are easily formed, is provided. The medical material contains a water-insoluble copolymer including a repeating unit (A) (which is derived from acryloylmorpholine, for example) and a repeating unit (B) (which is derived from methoxyethyl acrylate, for example), in which the water-insoluble copolymer has 5 mole % to 20 mole % of the repeating unit (A) with respect to all constituent units of the copolymer.

Claims (20)

1. A medical apparatus comprising:

a base material having a stepped surface; and

a coating layer containing a medical material on the surface of the base material, the medical material comprising:

a water-insoluble copolymer comprising:

a repeating unit (A) represented by the following Formula (1):

wherein in Formula (1), R 11 is a hydrogen atom or a methyl group and X is represented by the following Formula (1a):

wherein in Formula (1a), R 12 and R 13 are ethylene groups and Y is an oxygen atom; and

a repeating unit (B) represented by the following Formula (2):

wherein in Formula (2), R 21 is a hydrogen atom or a methyl group, R 22 is an alkylene group having 1 to 4 carbon atoms, and R 23 is an alkyl group having 1 to 4 carbon atoms,

wherein the water-insoluble copolymer has 6 mole % to 19 mole % of the repeating unit (A) with respect to all constituent units of the copolymer.

2. The medical apparatus according to claim 1 , wherein the copolymer has 81 mole % to 94 mole % of the repeating unit (B) with respect to all constituent units of the copolymer.

3. The medical apparatus according to claim 1 , wherein the total amount of the repeating unit (A) and the repeating unit (B) is 100 mole % with respect to all constituent units of the copolymer.

4. The medical apparatus according to claim 1 , wherein in Formula (1), R 11 is hydrogen.

5. The medical material apparatus according to claim 1 , wherein in Formula (2), R 21 is hydrogen.

6. The medical apparatus according to claim 1 , wherein in Formula (2), R 22 is a straight or branched-chain alkylene group having 1 to 3 carbon atoms.

7. The medical apparatus according to claim 1 , wherein in Formula (2), R 23 is a straight or branched-chain alkyl group having 1 to 3 carbon atoms.

8. The medical apparatus according to claim 1 , wherein the copolymer further comprises a third repeating unit in an amount of less than or equal to 15 mole % with respect to all constituent units of the copolymer.

9. The medical apparatus according to claim 2 , wherein in Formula (2), R 21 is hydrogen, R 22 is a straight or branched-chain alkylene group having 1 to 3 carbon atoms, and R 23 is a straight or branched-chain alkyl group having 1 to 3 carbon atoms.

10. The medical apparatus according to claim 9 , wherein in Formula (2), R 22 is an ethylene, and R 23 is a methylene.

11. The medical apparatus according to claim 10 , wherein the total amount of the repeating unit (A) and the repeating unit (B) is 100 mole % with respect to all constituent units of the copolymer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2015
From: ANZAI, TAKAO
To: TERUMO KABUSHIKI KAISHA
Reel/Frame 034996/0936 →
Priority Claims (1)
JP 2014-033408 · Feb 24, 2014 · national
Continuity (1)
Related Publication 20150238664A1 · Aug 27, 2015